Form 4 for ILMN ILLUMINA, INC.
Accepted 2022-03-03 00:00:00 ET · period of report 2022-03-01 · accession 0001127602-22-008112 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-03 | 2022-03-01 | ILMN | Febbo Phillip G. | SVP Chief Medical Off | A - Grant | $0.00 | +3,029 | 7,893 | +62% | $0 |
| D | 2022-03-03 | 2022-03-01 | ILMN | Febbo Phillip G. | SVP Chief Medical Off | A - Grant | $0.00 | +9,085 | 9,085 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-01 | A | A | 3,029 | $0.00 | 7,893 | D | — | — | (F1) Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2022, November 5, 2023, November 5, 2024, and November 5, 2025, subject to the awardee's continuing status as a service provider on such dates. |
| 2 | Derivative | Performance Shares | 2022-03-01 | A | A | 9,085 | $0.00 | 9,085 | D | — · — to 2024-12-29 | 9,085 Common Stock | (F2) Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 200% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. |